Roy Helmy, PhD

Research Fellow, Merck & Co. Inc.

Articles by Roy Helmy, PhD

技術資料

Two Options for Analyzing Potential Genotoxic Impurities in Active Pharmaceutical Ingredients
23 Oct 2020
Read Now